![Jerome Dvonch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jerome Dvonch
Finanzdirektor/CFO bei
SONOMA PHARMACEUTICALS, INC.
Vermögen: 5 202 $ am 30.06.2026
Profil
Jerome J.
Dvonch is currently Chief Financial Officer at Sonoma Pharmaceuticals, Inc. since 2023.
Former positions include Chief Financial Officer at Sonoma Pharmaceuticals, Inc. from 2020 to 2022; Director-Finance & External Reporting at NeoGenomics Laboratories, Inc. from 2005 to 2015; Chief Accounting Officer & Finance Director at NeoGenomics, Inc. in 2011; Associate Director-Financial Planning & Analysis at Protein Design Labs, Inc. from 2004 to 2005; Associate Director-Financial Analysis & Reporting at Exelixis, Inc. from 2000 to 2004; Manager-Business Analysis at PharmChem, Inc.; and Controller, SVP-Finance & Accounting at Spine Center Atlanta.
Education includes an MBA from Rochester Christian University and an undergraduate degree from Niagara University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.07.2026 | 4.229 ( 0,09 % ) | 5 202 $ | 30.06.2026 |
Aktive Positionen von Jerome Dvonch
| Unternehmen | Position | Beginn |
|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 07.04.2023 |
Ehemalige bekannte Positionen von Jerome Dvonch
| Unternehmen | Position | Ende |
|---|---|---|
| SONOMA PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 03.10.2022 |
NeoGenomics Laboratories, Inc.
 NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services Operates medical laboratories for diagnosing cancer | Finanzdirektor/CFO | 01.07.2015 |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Corporate Officer/Principal | 01.07.2005 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01.06.2004 |
Spine Center Atlanta
 Spine Center Atlanta Medical/Nursing ServicesHealth Services Operates as a spine and orthopedic care treatment center | Comptroller/Controller/Auditor | - |
Ausbildung von Jerome Dvonch
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
46
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
PharmChem, Inc.
 PharmChem, Inc. Medical/Nursing ServicesHealth Services Provides integrated drug testing services | Health Services |
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeoGenomics, Inc.
 NeoGenomics, Inc. Medical/Nursing ServicesHealth Services Provides genetic and molecular testing services | Health Services |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Sonoma Pharmaceuticals, Inc.
 Sonoma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells stabilized hypochlorous acid | Health Technology |
Niagara University
 Niagara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeoGenomics Laboratories, Inc.
NeoGenomics Laboratories, Inc. Medical/Nursing ServicesHealth Services Operates medical laboratories for diagnosing cancer | Health Services |
Spine Center Atlanta
Spine Center Atlanta Medical/Nursing ServicesHealth Services Operates as a spine and orthopedic care treatment center | Health Services |
